Skip to main content

Table 3 Experienced side effects in both groups

From: Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial

Variable

Clarithromycin-based regimen (n = 116)

Levofloxacin-based regimen (n = 117)

χ2

P

Epigastric pain

20 (17.2)

16 (13.7)

0.56

0.452

Vomiting

6 (5.1)

5 (4.3)

0.05

0.751

Diarrhoea

6 (5.1)

4 (3.4)

0.41

0.523

Nausea

13 (11.2)

14 (12.3)

0.04

0.844

Bloating

8 (6.9)

5 (4.3)

0.73

0.392

Change in taste

17 (14.7)

14 (12.0)

0.12

0.731

Skin rash

1 (0.9)

1 (0.9)

0.0

1.000